Skip to main content
. 2014 Mar 11;2014:683515. doi: 10.1155/2014/683515

Figure 7.

Figure 7

Patients reaching HbA1c target of ≤7% (a) and ≤6.5% (b) at baseline and end of observation time after treatment with testosterone undecanoate injections for up to 6 years.